# A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

> **NCT04862884** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Pain

## Interventions

- **DRUG:** HRS4800 tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04862884
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-03
- **Primary completion:** 2021-09-03
- **Final completion:** 2021-09-24
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862884, "A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04862884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*